PAZOPANIB HYDROCHLORIDE (PAZOPANIB HYDROCHLORIDE) — FDA Approval ANDA217713 (APOTEX)
PAZOPANIB HYDROCHLORIDE (PAZOPANIB HYDROCHLORIDE) — FDA Approval ANDA217713 (APOTEX) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: PAZOPANIB HYDROCHLORIDE; Active ingredients: PAZOPANIB HYDROCHLORIDE; Application number: ANDA217713.
| Brand name | PAZOPANIB HYDROCHLORIDE |
|---|---|
| Active ingredients | PAZOPANIB HYDROCHLORIDE |
| Application number | ANDA217713 |
| Sponsor | APOTEX |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 20231019 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →